ocr: TABLE 44.6-9. Ongoing Trials* in CS Iand II Hodgkin's Disease Patients With Poor Prognostic Features Clinical Trial Stage Arm 1 Arm 2 EORTC H7U I-II EBVP X 6 + IF MOPP/ABV X 6 + IF RT EORTC H8U I-II MOPP/ABV X 6 + IF MOPP/ABV X 4 + IF RTvs MOPPABVD X 4 + STLI MSKCC I-II MOPP X 4 + mantle RT TBV X 4 + mantle RT Milan group IA, IB, ABVD X 4 + IF ABVD X 4 + STLI IIA GHSG HD-1 I-II COPPABVD X 4 + STLI 40 Gy vs 20 Gy RT EORTC, European Organization for the Research and Treatment ofCancer; MSKCC, Memorial Sloan- Kettering Cancer Center; GHSG, German Hodgkin's Study Group; STLI-Splenic RT, subtotal l ...
